Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability

Al-Saktawi, 2003, Genetic background determines phenotypic severity of the Plp rumpshaker mutation, J. Neurosci. Res., 72, 12, 10.1002/jnr.10561 Bonnet-Dupeyron, 2008, PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations, Hum. Mutat., 29, 1028, 10.1002/humu.20758 Cailloux, 2000, Genotype–phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations, Eur. J. Hum. Genet., 8, 837, 10.1038/sj.ejhg.5200537 Campagnoni, 1988, Cellular and molecular aspects of myelin protein gene expression, Mol. Neurobiol., 2, 41, 10.1007/BF02935632 DeLuca, 2004, Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts, Brain, 127, 1009, 10.1093/brain/awh118 Edgar, 2004, Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia, J. Cell Biol., 166, 121, 10.1083/jcb.200312012 Garbern, 2002 Garbern, 2002, Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation, Brain, 125, 551, 10.1093/brain/awf043 Griffiths, 1998, Current concepts of PLP and its role in the nervous system, Microsc. Res. Tech., 41, 344, 10.1002/(SICI)1097-0029(19980601)41:5<344::AID-JEMT2>3.0.CO;2-Q Griffiths, 1998, Axonal swellings and degeneration in mice lacking the major proteolipid of myelin, Science, 280, 1610, 10.1126/science.280.5369.1610 Gschwind, 1998, Introduction of hereditary disease-associated mutations into the beta-amyloid precursor protein gene of mouse embryonic stem cells: a comparison of homologous recombination methods, Mol. Cell. Biol., 18, 4651, 10.1128/MCB.18.8.4651 Hasty, 1991, Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells, Nature, 350, 243, 10.1038/350243a0 Hasty, 1991, The length of homology required for gene targeting in embryonic stem cells, Mol. Cell. Biol., 11, 5586, 10.1128/MCB.11.11.5586 Hobson, 2002, A PLP splicing abnormality is associated with an unusual presentation of PMD, Ann. Neurol., 52, 477, 10.1002/ana.10320 Hobson, 2006, Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes, Hum. Mutat., 27, 69, 10.1002/humu.20276 Kanfer, 1989, Developmental expression of myelin proteolipid, basic protein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase transcripts in different rat brain regions, J. Mol. Neurosci., 1, 39, 10.1007/BF02918889 Klugmann, 1997, Assembly of CNS myelin in the absence of proteolipid protein, Neuron, 18, 59, 10.1016/S0896-6273(01)80046-5 LeVine, 1990, Developmental expression of proteolipid protein and DM20 mRNAs and proteins in the rat brain, Dev. Neurosci., 12, 235, 10.1159/000111853 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 Luzi, 2001, Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease), Mol. Genet. Metab., 73, 211, 10.1006/mgme.2001.3194 Matlin, 2005, Understanding alternative splicing: towards a cellular code, Nat. Rev., Mol. Cell Biol., 6, 386, 10.1038/nrm1645 McIlwain, 2001, The use of behavioral test batteries: effects of training history, Physiol. Behav., 73, 705, 10.1016/S0031-9384(01)00528-5 Mimault, 1999, Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not, Am. J. Hum. Genet., 65, 360, 10.1086/302483 Moy, 2006, Mouse models of autism spectrum disorders: the challenge for behavioral genetics, Am. J. Med. Genet., C. Semin. Med. Genet., 142, 40, 10.1002/ajmg.c.30081 Moy, 2007, Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains, Behav. Brain Res., 176, 4, 10.1016/j.bbr.2006.07.030 Nave, 1987, Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin, Proc. Natl. Acad. Sci. U. S. A., 84, 5665, 10.1073/pnas.84.16.5665 Norton, 1973, Myelination in rat brain: method of myelin isolation, J. Neurochem., 21, 749, 10.1111/j.1471-4159.1973.tb07519.x Papadopoulos, 2006, Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat, Exp. Neurol., 197, 373, 10.1016/j.expneurol.2005.10.033 Rosenbluth, 2006, Subtle myelin defects in PLP-null mice, Glia, 54, 172, 10.1002/glia.20370 Shy, 2003, Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy, Ann. Neurol., 53, 354, 10.1002/ana.10466 Sporkel, 2002, Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development, Glia, 37, 19, 10.1002/glia.10014 Stecca, 2000, The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin, J. Neurosci., 20, 4002, 10.1523/JNEUROSCI.20-11-04002.2000 Timsit, 1992, DM-20 mRNA is expressed during the embryonic development of the nervous system of the mouse, J. Neurochem., 58, 1172, 10.1111/j.1471-4159.1992.tb09378.x Wang, 2006, PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer, J. Cell. Biochem., 97, 999, 10.1002/jcb.20692 Wang, 2007, PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes, Nucleic Acids Res., 35, 4164, 10.1093/nar/gkm387 Yool, 2001, Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons, J. Neurosci. Res., 63, 151, 10.1002/1097-4547(20010115)63:2<151::AID-JNR1007>3.0.CO;2-Y